Insider Transactions in Q2 2025 at Janux Therapeutics, Inc. (JANX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2025
|
Andrew Hollman Meyer Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,334
-3.9%
|
$100,020
$30.0 P/Share
|
|
Apr 21
2025
|
Andrew Hollman Meyer Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,334
+3.75%
|
$13,336
$4.21 P/Share
|